Mechanisms of isoflurane-induced myocardial preconditioning in rabbits

Isoflurane has cardioprotective effects that mimic the ischemic preconditioning phenomenon. Because adenosine triphosphate-sensitive potassium channels and adenosine receptors are implicated in ischemic preconditioning, the authors wanted to determine whether the preconditioning effect of isoflurane...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesiology (Philadelphia) 1999-03, Vol.90 (3), p.812-821
Hauptverfasser: ISMAEIL, M. S, TKACHENKO, I, GAMPERL, A. K, HICKEY, R. F, CASON, B. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 821
container_issue 3
container_start_page 812
container_title Anesthesiology (Philadelphia)
container_volume 90
creator ISMAEIL, M. S
TKACHENKO, I
GAMPERL, A. K
HICKEY, R. F
CASON, B. A
description Isoflurane has cardioprotective effects that mimic the ischemic preconditioning phenomenon. Because adenosine triphosphate-sensitive potassium channels and adenosine receptors are implicated in ischemic preconditioning, the authors wanted to determine whether the preconditioning effect of isoflurane is mediated through these pathways. Myocardial infarct size was measured in seven groups of propofol-anesthetized rabbits, each subjected to 30 min of anterolateral coronary occlusion followed by 3 h of reperfusion. Groups differed only in the pretreatments given, and controls received no pretreatment. An ischemia-preconditioned group was pretreated with 5 min of coronary occlusion and 15 min of reperfusion. An isoflurane-preconditioned group was pretreated with 15 min end-tidal isoflurane, 1.1%, and then 15 min of washout. An isoflurane-plus-glyburide group was administered 0.33 mg/kg glyburide intravenously before isoflurane pretreatment. An isoflurane plus 8-(p-sulfophenyl)-theophylline (SPT) group received 7.5 mg/kg SPT intravenously before isoflurane. Additional groups were administered identical doses of glyburide or SPT, but they were not pretreated with isoflurane. Infarct size and area at risk were defined by staining. Data were analyzed by analysis of variance or covariance. Infarct size, expressed as a percentage of the area at risk (IS:AR) was 30.2+/-11% (SD) in controls. Ischemic preconditioning and isoflurane preexposure reduced myocardial infarct size significantly, to 8.3+/-5% and 13.4+/-8.2% (P
doi_str_mv 10.1097/00000542-199903000-00024
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00000542_199903000_00024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10078683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-7e5a27ae86420ac875f27dd7be709b87e5bc4d65fbd6c3d36e9c72d9fbe4ee313</originalsourceid><addsrcrecordid>eNpNkLlOAzEQhi0EIiHwCsgFrcHHem2XKCIBKYgG6pVPMNr1RnZS5O1xSDhGGs31_1N8AECCbwlW4g7vgzcUEaUUZnVANWlzAqaEU4kIEfwUTOuOIYYpnYCLUj7rKDiT52BCaidbyaZg8ezth06xDAWOAcYyhn6bdfIoJre13sFhN1qdXdQ9XGdvx-TiJo4ppncYE8zamLgpl-As6L74q2OdgbfFw-v8Ea1elk_z-xWyTOENEp5rKrSXbUOxtlLwQIVzwniBlZH1bGzjWh6May1zrPXKCupUML7xnhE2A_Lw1-axlOxDt85x0HnXEdzt0XQ_aLpfNN03mmq9PljXWzN49894YFEFN0eBLlb3oVKwsfzpBMOtEOwLtUVtDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mechanisms of isoflurane-induced myocardial preconditioning in rabbits</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>ISMAEIL, M. S ; TKACHENKO, I ; GAMPERL, A. K ; HICKEY, R. F ; CASON, B. A</creator><creatorcontrib>ISMAEIL, M. S ; TKACHENKO, I ; GAMPERL, A. K ; HICKEY, R. F ; CASON, B. A</creatorcontrib><description>Isoflurane has cardioprotective effects that mimic the ischemic preconditioning phenomenon. Because adenosine triphosphate-sensitive potassium channels and adenosine receptors are implicated in ischemic preconditioning, the authors wanted to determine whether the preconditioning effect of isoflurane is mediated through these pathways. Myocardial infarct size was measured in seven groups of propofol-anesthetized rabbits, each subjected to 30 min of anterolateral coronary occlusion followed by 3 h of reperfusion. Groups differed only in the pretreatments given, and controls received no pretreatment. An ischemia-preconditioned group was pretreated with 5 min of coronary occlusion and 15 min of reperfusion. An isoflurane-preconditioned group was pretreated with 15 min end-tidal isoflurane, 1.1%, and then 15 min of washout. An isoflurane-plus-glyburide group was administered 0.33 mg/kg glyburide intravenously before isoflurane pretreatment. An isoflurane plus 8-(p-sulfophenyl)-theophylline (SPT) group received 7.5 mg/kg SPT intravenously before isoflurane. Additional groups were administered identical doses of glyburide or SPT, but they were not pretreated with isoflurane. Infarct size and area at risk were defined by staining. Data were analyzed by analysis of variance or covariance. Infarct size, expressed as a percentage of the area at risk (IS:AR) was 30.2+/-11% (SD) in controls. Ischemic preconditioning and isoflurane preexposure reduced myocardial infarct size significantly, to 8.3+/-5% and 13.4+/-8.2% (P&lt;0.05), respectively. Both glyburide and SPT pretreatment eliminated the preconditioning-like effect of isoflurane (IS:AR = 30.0+/-9.1% and 29.2+/-12.6%, respectively; P = not significant). Neither glyburide nor SPF alone increased infarct size (IS:AR = 33.9+/-7.6% and 31.8+/-12.7%, respectively; P = not significant). Glyburide and SPT abolished the preconditioning-like effects of isoflurane but did not increase infarct size when administered in the absence of isoflurane. Isoflurane-induced preconditioning and ischemia-induced preconditioning share similar mechanisms, which include activation of adenosine triphosphate-sensitive potassium channels and adenosine receptors.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-199903000-00024</identifier><identifier>PMID: 10078683</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Anesthetics, Inhalation - administration &amp; dosage ; Anesthetics, Inhalation - adverse effects ; Animals ; Biological and medical sciences ; Cardiovascular system ; Hemodynamics - drug effects ; Injections, Intravenous ; Ischemic Preconditioning, Myocardial ; Isoflurane - administration &amp; dosage ; Isoflurane - adverse effects ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; Potassium Channels - physiology ; Rabbits ; Ventricular Fibrillation</subject><ispartof>Anesthesiology (Philadelphia), 1999-03, Vol.90 (3), p.812-821</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-7e5a27ae86420ac875f27dd7be709b87e5bc4d65fbd6c3d36e9c72d9fbe4ee313</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1730677$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10078683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ISMAEIL, M. S</creatorcontrib><creatorcontrib>TKACHENKO, I</creatorcontrib><creatorcontrib>GAMPERL, A. K</creatorcontrib><creatorcontrib>HICKEY, R. F</creatorcontrib><creatorcontrib>CASON, B. A</creatorcontrib><title>Mechanisms of isoflurane-induced myocardial preconditioning in rabbits</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Isoflurane has cardioprotective effects that mimic the ischemic preconditioning phenomenon. Because adenosine triphosphate-sensitive potassium channels and adenosine receptors are implicated in ischemic preconditioning, the authors wanted to determine whether the preconditioning effect of isoflurane is mediated through these pathways. Myocardial infarct size was measured in seven groups of propofol-anesthetized rabbits, each subjected to 30 min of anterolateral coronary occlusion followed by 3 h of reperfusion. Groups differed only in the pretreatments given, and controls received no pretreatment. An ischemia-preconditioned group was pretreated with 5 min of coronary occlusion and 15 min of reperfusion. An isoflurane-preconditioned group was pretreated with 15 min end-tidal isoflurane, 1.1%, and then 15 min of washout. An isoflurane-plus-glyburide group was administered 0.33 mg/kg glyburide intravenously before isoflurane pretreatment. An isoflurane plus 8-(p-sulfophenyl)-theophylline (SPT) group received 7.5 mg/kg SPT intravenously before isoflurane. Additional groups were administered identical doses of glyburide or SPT, but they were not pretreated with isoflurane. Infarct size and area at risk were defined by staining. Data were analyzed by analysis of variance or covariance. Infarct size, expressed as a percentage of the area at risk (IS:AR) was 30.2+/-11% (SD) in controls. Ischemic preconditioning and isoflurane preexposure reduced myocardial infarct size significantly, to 8.3+/-5% and 13.4+/-8.2% (P&lt;0.05), respectively. Both glyburide and SPT pretreatment eliminated the preconditioning-like effect of isoflurane (IS:AR = 30.0+/-9.1% and 29.2+/-12.6%, respectively; P = not significant). Neither glyburide nor SPF alone increased infarct size (IS:AR = 33.9+/-7.6% and 31.8+/-12.7%, respectively; P = not significant). Glyburide and SPT abolished the preconditioning-like effects of isoflurane but did not increase infarct size when administered in the absence of isoflurane. Isoflurane-induced preconditioning and ischemia-induced preconditioning share similar mechanisms, which include activation of adenosine triphosphate-sensitive potassium channels and adenosine receptors.</description><subject>Anesthetics, Inhalation - administration &amp; dosage</subject><subject>Anesthetics, Inhalation - adverse effects</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Hemodynamics - drug effects</subject><subject>Injections, Intravenous</subject><subject>Ischemic Preconditioning, Myocardial</subject><subject>Isoflurane - administration &amp; dosage</subject><subject>Isoflurane - adverse effects</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium Channels - physiology</subject><subject>Rabbits</subject><subject>Ventricular Fibrillation</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkLlOAzEQhi0EIiHwCsgFrcHHem2XKCIBKYgG6pVPMNr1RnZS5O1xSDhGGs31_1N8AECCbwlW4g7vgzcUEaUUZnVANWlzAqaEU4kIEfwUTOuOIYYpnYCLUj7rKDiT52BCaidbyaZg8ezth06xDAWOAcYyhn6bdfIoJre13sFhN1qdXdQ9XGdvx-TiJo4ppncYE8zamLgpl-As6L74q2OdgbfFw-v8Ea1elk_z-xWyTOENEp5rKrSXbUOxtlLwQIVzwniBlZH1bGzjWh6May1zrPXKCupUML7xnhE2A_Lw1-axlOxDt85x0HnXEdzt0XQ_aLpfNN03mmq9PljXWzN49894YFEFN0eBLlb3oVKwsfzpBMOtEOwLtUVtDw</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>ISMAEIL, M. S</creator><creator>TKACHENKO, I</creator><creator>GAMPERL, A. K</creator><creator>HICKEY, R. F</creator><creator>CASON, B. A</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19990301</creationdate><title>Mechanisms of isoflurane-induced myocardial preconditioning in rabbits</title><author>ISMAEIL, M. S ; TKACHENKO, I ; GAMPERL, A. K ; HICKEY, R. F ; CASON, B. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-7e5a27ae86420ac875f27dd7be709b87e5bc4d65fbd6c3d36e9c72d9fbe4ee313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Anesthetics, Inhalation - administration &amp; dosage</topic><topic>Anesthetics, Inhalation - adverse effects</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Hemodynamics - drug effects</topic><topic>Injections, Intravenous</topic><topic>Ischemic Preconditioning, Myocardial</topic><topic>Isoflurane - administration &amp; dosage</topic><topic>Isoflurane - adverse effects</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium Channels - physiology</topic><topic>Rabbits</topic><topic>Ventricular Fibrillation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ISMAEIL, M. S</creatorcontrib><creatorcontrib>TKACHENKO, I</creatorcontrib><creatorcontrib>GAMPERL, A. K</creatorcontrib><creatorcontrib>HICKEY, R. F</creatorcontrib><creatorcontrib>CASON, B. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ISMAEIL, M. S</au><au>TKACHENKO, I</au><au>GAMPERL, A. K</au><au>HICKEY, R. F</au><au>CASON, B. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanisms of isoflurane-induced myocardial preconditioning in rabbits</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>90</volume><issue>3</issue><spage>812</spage><epage>821</epage><pages>812-821</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Isoflurane has cardioprotective effects that mimic the ischemic preconditioning phenomenon. Because adenosine triphosphate-sensitive potassium channels and adenosine receptors are implicated in ischemic preconditioning, the authors wanted to determine whether the preconditioning effect of isoflurane is mediated through these pathways. Myocardial infarct size was measured in seven groups of propofol-anesthetized rabbits, each subjected to 30 min of anterolateral coronary occlusion followed by 3 h of reperfusion. Groups differed only in the pretreatments given, and controls received no pretreatment. An ischemia-preconditioned group was pretreated with 5 min of coronary occlusion and 15 min of reperfusion. An isoflurane-preconditioned group was pretreated with 15 min end-tidal isoflurane, 1.1%, and then 15 min of washout. An isoflurane-plus-glyburide group was administered 0.33 mg/kg glyburide intravenously before isoflurane pretreatment. An isoflurane plus 8-(p-sulfophenyl)-theophylline (SPT) group received 7.5 mg/kg SPT intravenously before isoflurane. Additional groups were administered identical doses of glyburide or SPT, but they were not pretreated with isoflurane. Infarct size and area at risk were defined by staining. Data were analyzed by analysis of variance or covariance. Infarct size, expressed as a percentage of the area at risk (IS:AR) was 30.2+/-11% (SD) in controls. Ischemic preconditioning and isoflurane preexposure reduced myocardial infarct size significantly, to 8.3+/-5% and 13.4+/-8.2% (P&lt;0.05), respectively. Both glyburide and SPT pretreatment eliminated the preconditioning-like effect of isoflurane (IS:AR = 30.0+/-9.1% and 29.2+/-12.6%, respectively; P = not significant). Neither glyburide nor SPF alone increased infarct size (IS:AR = 33.9+/-7.6% and 31.8+/-12.7%, respectively; P = not significant). Glyburide and SPT abolished the preconditioning-like effects of isoflurane but did not increase infarct size when administered in the absence of isoflurane. Isoflurane-induced preconditioning and ischemia-induced preconditioning share similar mechanisms, which include activation of adenosine triphosphate-sensitive potassium channels and adenosine receptors.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>10078683</pmid><doi>10.1097/00000542-199903000-00024</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-3022
ispartof Anesthesiology (Philadelphia), 1999-03, Vol.90 (3), p.812-821
issn 0003-3022
1528-1175
language eng
recordid cdi_crossref_primary_10_1097_00000542_199903000_00024
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Anesthetics, Inhalation - administration & dosage
Anesthetics, Inhalation - adverse effects
Animals
Biological and medical sciences
Cardiovascular system
Hemodynamics - drug effects
Injections, Intravenous
Ischemic Preconditioning, Myocardial
Isoflurane - administration & dosage
Isoflurane - adverse effects
Medical sciences
Miscellaneous
Pharmacology. Drug treatments
Potassium Channels - physiology
Rabbits
Ventricular Fibrillation
title Mechanisms of isoflurane-induced myocardial preconditioning in rabbits
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A32%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanisms%20of%20isoflurane-induced%20myocardial%20preconditioning%20in%20rabbits&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=ISMAEIL,%20M.%20S&rft.date=1999-03-01&rft.volume=90&rft.issue=3&rft.spage=812&rft.epage=821&rft.pages=812-821&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-199903000-00024&rft_dat=%3Cpubmed_cross%3E10078683%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10078683&rfr_iscdi=true